Clinical Trial Update: Pepsin As A Biomarker For Aspiration

View source ↗

Summary

The trial update notes completion of a study evaluating pepsin as a biomarker for aspiration in patients with aspiration and gastroesophageal reflux.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aspiration
• Gastroesophageal Reflux Disease

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Aspiration, Gastroesophageal Reflux | Status: COMPLETED